About the Webinar
Who is going to progress? When?
One of the most pressing concerns in primary eye care is accurately predicting which diabetic retinopathy patient is going to progress. The challenge is knowing when to refer the patient out — not too soon and certainly not too late. The key takeaway? Structural health assessed through imaging is only half of it. Functional diagnostics are vital.
In this webinar, I’m going to present the latest diagnostic tools and strategies to provide the most accurate and predictive patient information. I’ll be focusing on the portable and non-invasive RETeval® Device. It combines functional retina cell stress testing with pupil light response. This powerful combination provides a superior risk assessment for which patients are going to require an ocular intervention, compared to the current Standard of Care.
In this webinar, I’m going to present the latest diagnostic tools and strategies to provide the most accurate and predictive patient information. I’ll be focusing on the portable and non-invasive RETeval® Device. It combines functional retina cell stress testing with pupil light response. This powerful combination provides a superior risk assessment for which patients are going to require an ocular intervention, compared to the current Standard of Care.
Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to